1Samadi AR, Mayberry RM, Zaidi AA, et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States[J]. Obstet Gynecol, 1996, 87(4): 557-563.
2丰有吉,沈铿.妇产科学[M].2版.北京:人民卫生出版社,2010:325.
3ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampia[J]. Obstet Gynecol, 2002, 99(1): 159-167.
4Steegers EA, Von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia[J]. Lancet, 2010, 376(9741): 631-644.
5Duley L. The global impact of pre-eclampsia and eclampsia[J]. Semin Perinatol, 2009, 33(3): 130-137.
6Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. the eighth report of the confidential enquiries into maternal deaths in the United Kingdom[J]. BJOG, 2011, 118(Suppl 1): 1-203.
7Mander R, Smith GD. Saving mothers' lives (formerly why mothers die)" reviewing maternal deaths to make motherhood safer 2003- 2005[J]. Midwifery, 2008, 24(1): 8-12.
8Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy[J]. Hypertension, 2008, 51(4): 960-969.
9Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy[J]. Cochrane Database Syst Rev, 2013, 7: CD001449.
10National Collaborating Centre for Women's and Children's Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. (RCOG Press, London (2010 Aug). NICE Clinical Guidelines, No. 107[M/OL]. London: ASOGPress, 2010. www.ncbi.nlm.nih.gov/books/NBK62652 .
2Cifkova R. Hypertension in pregnancy. Cas Lek Cesk, 2009,148: 65 -71.
3Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. BJOG, 2000,107:299-307.
4Oremus M, Wolfson C, Perrault A, et al. IntelTater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord, 2001,12:232-236.
5Fenakel K, Fenakel G, Appehnan Z, et al. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol, 1991,77 : 331- 337.
6Martins-Costa S, Ramos JG, Bmxos E, et al. Randomized, controlled trial of hydralazine versus nifedipine in preeclamptic women with acute hypertension. Clin Exp Hypertens B, 1992, 11 : 25 -44.
7Walss Rodriguez R J, Flores Padilla LM. Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents. Ginecol Obstet Mex, 1993, 61:76-79.
8Jayawardana J, Lekamge N. A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Ceylon Med J, 1994,39:87-90.
9Kwawukume EY, Ghosh TS. Oral nifedipine therapy in the management of severe preeclampsia. Int J Gynaecol Obstet, 1995, 49 : 265-269.
10Visser W, Wallenburg HC. A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe pre-eclampsia. J Hypertens, 1995,13:791-795.
